MDM2 and chronic kidney disease: Given our data showing significant alterations in KYN metabolism and excitotoxic metabolites in the Mdm2-cKO, IR, and ade-CKD mice brains, it is plausible that kidney dysfunction–driven systemic inflammation exacerbates blood-brain barrier dysfunction and promotes neuroinflammatory changes, further contributing to neuronal impairment.